Clinical Trials Update: Aug. 7, 2003
Rheumatoid Arthritis Prostate Cancer Urinary Incontinence
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study to test the safety and tolerability of an investigational drug in rheumatoid arthritis patients who are taking oral methotrexate. Volunteers 18 to 75 years old whose arthritis is active despite taking oral methotrexate may be eligible. Research site located in Manhasset, New York.
A study of an investigational medication for the treatment of prostate cancer. Volunteers 18 or older who have histologically documented adenocarcinoma of the prostate with a Gleason Score of 7 or lower, whose cancer has progressed while on hormone therapy and has spread outside the prostate (metastatic) to lymph nodes or bone may be eligible. Research sites located throughout the United States.
A research study to test the effectiveness of an investigational drug in women with urinary incontinence symptoms. Female volunteers 18 years or older who experience at least 4 episodes of urine leakage in a week and who are not pregnant may be eligible. Research site located in Staten Island, New York.
Copyright 2003 CenterWatch. All rights reserved.